Beijing Tongrentang Future Growth
Future criteria checks 1/6
Beijing Tongrentang is forecast to grow earnings and revenue by 15.6% and 9.2% per annum respectively. EPS is expected to grow by 15.6% per annum. Return on equity is forecast to be 12.5% in 3 years.
Key information
15.6%
Earnings growth rate
15.61%
EPS growth rate
Pharmaceuticals earnings growth | 14.8% |
Revenue growth rate | 9.2% |
Future return on equity | 12.54% |
Analyst coverage | Good |
Last updated | 06 May 2025 |
Recent future growth updates
Recent updates
Investors Don't See Light At End Of Beijing Tongrentang Co., Ltd's (SHSE:600085) Tunnel
Mar 07Is Beijing Tongrentang (SHSE:600085) A Risky Investment?
Jan 23Beijing Tongrentang Co., Ltd's (SHSE:600085) Shares May Have Run Too Fast Too Soon
Nov 21Beijing Tongrentang's (SHSE:600085) Profits May Not Reveal Underlying Issues
Sep 06Earnings Miss: Beijing Tongrentang Co., Ltd Missed EPS By 20% And Analysts Are Revising Their Forecasts
Sep 03Here's Why Beijing Tongrentang (SHSE:600085) Has Caught The Eye Of Investors
Aug 17Is Beijing Tongrentang (SHSE:600085) Using Too Much Debt?
Jul 15Beijing Tongrentang Co., Ltd (SHSE:600085) Shares Could Be 21% Below Their Intrinsic Value Estimate
Jun 09Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 23,743 | 2,344 | 4,094 | 3,791 | 5 |
12/31/2026 | 22,179 | 2,048 | 2,975 | 3,217 | 10 |
12/31/2025 | 19,831 | 1,700 | 1,877 | 4,844 | 4 |
3/31/2025 | 18,606 | 1,533 | 1,350 | 1,845 | N/A |
12/31/2024 | 18,597 | 1,526 | 241 | 761 | N/A |
9/30/2024 | 17,959 | 1,628 | -1,028 | -577 | N/A |
6/30/2024 | 17,863 | 1,703 | -892 | -483 | N/A |
3/31/2024 | 17,985 | 1,721 | 99 | 472 | N/A |
12/31/2023 | 17,861 | 1,669 | 1,545 | 1,869 | N/A |
9/30/2023 | 18,194 | 1,815 | 2,767 | 3,075 | N/A |
6/30/2023 | 17,626 | 1,670 | 3,242 | 3,578 | N/A |
3/31/2023 | 16,562 | 1,551 | 2,973 | 3,306 | N/A |
12/31/2022 | 15,372 | 1,427 | 2,764 | 3,094 | N/A |
9/30/2022 | 14,820 | 1,310 | 3,069 | 3,429 | N/A |
6/30/2022 | 14,751 | 1,347 | 3,040 | 3,426 | N/A |
3/31/2022 | 14,850 | 1,309 | 3,030 | 3,397 | N/A |
12/31/2021 | 14,603 | 1,227 | 2,955 | 3,426 | N/A |
9/30/2021 | 14,456 | 1,236 | 2,021 | 2,777 | N/A |
6/30/2021 | 14,182 | 1,175 | 2,116 | 2,877 | N/A |
3/31/2021 | 13,502 | 1,111 | 1,572 | 2,785 | N/A |
12/31/2020 | 12,826 | 1,031 | 1,024 | 2,175 | N/A |
9/30/2020 | 12,371 | 850 | 1,400 | 2,206 | N/A |
6/30/2020 | 12,124 | 805 | 1,609 | 2,385 | N/A |
3/31/2020 | 12,396 | 875 | 1,802 | 2,203 | N/A |
12/31/2019 | 13,277 | 985 | 1,810 | 2,274 | N/A |
9/30/2019 | 13,691 | 1,135 | 1,717 | 2,285 | N/A |
6/30/2019 | 14,098 | 1,156 | 1,369 | 2,007 | N/A |
3/31/2019 | 14,455 | 1,167 | 1,262 | 1,896 | N/A |
12/31/2018 | 14,209 | 1,134 | N/A | 1,928 | N/A |
9/30/2018 | 14,070 | 1,048 | N/A | 1,907 | N/A |
6/30/2018 | 13,644 | 1,057 | N/A | 1,598 | N/A |
3/31/2018 | 13,373 | 1,040 | N/A | 1,642 | N/A |
12/31/2017 | 13,376 | 1,017 | N/A | 1,473 | N/A |
9/30/2017 | 12,978 | 994 | N/A | 1,234 | N/A |
6/30/2017 | 12,705 | 970 | N/A | 1,245 | N/A |
3/31/2017 | 12,480 | 965 | N/A | 1,034 | N/A |
12/31/2016 | 12,091 | 933 | N/A | 1,046 | N/A |
9/30/2016 | 11,788 | 970 | N/A | 1,033 | N/A |
6/30/2016 | 11,588 | 949 | N/A | 910 | N/A |
3/31/2016 | 11,106 | 898 | N/A | 839 | N/A |
12/31/2015 | 10,897 | 875 | N/A | 835 | N/A |
9/30/2015 | 10,449 | 848 | N/A | 838 | N/A |
6/30/2015 | 10,190 | 828 | N/A | 792 | N/A |
3/31/2015 | 9,816 | 793 | N/A | 712 | N/A |
12/31/2014 | 9,686 | 764 | N/A | 696 | N/A |
9/30/2014 | 9,281 | 728 | N/A | 538 | N/A |
6/30/2014 | 9,134 | 709 | N/A | 524 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 600085's forecast earnings growth (15.6% per year) is above the savings rate (2.7%).
Earnings vs Market: 600085's earnings (15.6% per year) are forecast to grow slower than the CN market (23.6% per year).
High Growth Earnings: 600085's earnings are forecast to grow, but not significantly.
Revenue vs Market: 600085's revenue (9.2% per year) is forecast to grow slower than the CN market (12.4% per year).
High Growth Revenue: 600085's revenue (9.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 600085's Return on Equity is forecast to be low in 3 years time (12.5%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/05/15 13:11 |
End of Day Share Price | 2025/05/15 00:00 |
Earnings | 2025/03/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Beijing Tongrentang Co., Ltd is covered by 27 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Changming He | BOCI Research Ltd. |
Bo Li | BofA Global Research |
Songtao YE | Changjiang Securities Co. LTD. |